MELISSA ROBINSON
Family Nurse Practitioner · SYOSSET, NY
Individual Active NPI 1790314763
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 209 | 102,769 | $7,386,592 | $4,040,558 | $3,217,315 |
| 2023 | 69 | 57,006 | $5,350,339 | $3,009,068 | $2,395,199 |
| 2022 | 62 | 35,132 | $3,813,360 | $2,083,226 | $1,660,377 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 32,050 | $1 | $1 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 12,600 | $22 | $17 |
| J0485 | Injection, belatacept, 1 mg | 11,750 | $4 | $3 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 3,500 | $18 | $14 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,270 | $31 | $24 |
| J0225 | Injection, vutrisiran, 1 mg | 375 | $4,210 | $3,354 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 347 | $0 | $0 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 224 | $62 | $49 |
| 96372 | Injection of drug or substance under skin or into muscle | 69 | $14 | $11 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 61 | $125 | $98 |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 49 | $20 | $16 |
| 96415 | Administration of chemotherapy into vein, each additional hour | 44 | $27 | $22 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | F344859-01 | NY |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in New York
- NPI 1508301383
- NPI 1366838609
- NPI 1104244128
- NPI 1396409140
- NPI 1225526965
- NPI 1740847516
- NPI 1588599104
- NPI 1083532790
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.